Company intelligence / Profile preview

Codebreaker Labs

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Codebreaker is a stealth-stage biotechnology company dedicated to advancing the next generation of gene-editing medicines. Founded by world-renowned experts in functional genomics and cancer genetics, the company utilizes sophisticated CRISPR screening technologies to map the genetic drivers of disease with unprecedented precision. By integrating high-throughput experimental data with advanced computational modeling, Codebreaker aims to develop highly targeted therapies for complex conditions, including cancer and rare genetic disorders. The company is backed by leading life science venture capital firms and is positioned at the intersection of genomics and precision medicine.

Therapeutic areas: OncologyRare Diseases
Modalities: CRISPR-based therapyGene therapy
Industry: Biotech

Beyond the preview

Go deeper on Codebreaker Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Codebreaker Labs.

Explore the full profile